Panvax H1N1 vaccine New Zealand - English - Medsafe (Medicines Safety Authority)

panvax h1n1 vaccine

seqirus (nz) ltd - influenza virus a/california/7/2009 (h1n1) - like strain 15ug - suspension for injection - 15 mcg/0.5ml - active: influenza virus a/california/7/2009 (h1n1) - like strain 15ug excipient: calcium chloride dihydrate dibasic sodium phosphate monobasic potassium phosphate monobasic sodium phosphate dihydrate potassium chloride sodium chloride thiomersal water for injection - for active immunisation to prevent influenza disease caused by the influenza a(h1n1) virus, in adults, adolescents and children 10 years of age and older.

Vepacel New Zealand - English - Medsafe (Medicines Safety Authority)

vepacel

pharmacy retailing (nz) ltd t/a healthcare logistics - influenza vaccine whole virion, vero cell derived, inactivated 7.5ug (ha per dose a(h5n1)(a/vietnam/1203/2004)) - suspension for injection - 7.5 mcg/0.5ml - active: influenza vaccine whole virion, vero cell derived, inactivated 7.5ug (ha per dose a(h5n1)(a/vietnam/1203/2004)) excipient: polysorbate 80 sodium chloride trometamol water for injection - active immunisation against h5n1 subtype of influenza a virus. this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards as well as immunocompromised and chronically ill subjects following administration of two doses of vaccine prepared with h5n1 subtype strains. vepacel may only be marketed or distributed in accordance with the directives contained in the current version of the new zealand influenza pandemic action plan.

INFLUVAC Israel - English - Ministry of Health

influvac

abbott medical laboratories ltd, israel - a/cambodia/e0826360/2020 (h3n2)-like strain; a/victoria/2570/2019 (h1n1)pdm09-like strain; b/washington/02/2019 (b/victoria lineage)-like virus - suspension for injection - b/washington/02/2019 (b/victoria lineage)-like virus 15 mcg/dose / 0.5 ml; a/cambodia/e0826360/2020 (h3n2)-like strain 15 mcg / 0.5 ml; a/victoria/2570/2019 (h1n1)pdm09-like strain 15 mcg / 0.5 ml - influenza, inactivated, split virus or surface antigen - influenza, inactivated, whole virus - influenza virus vaccine.

INACTIVATED INFLUENZA VACCINE (SPLIT VIRON) 7.5 mcg ea %v/v Suspension for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

inactivated influenza vaccine (split viron) 7.5 mcg ea %v/v suspension for injection

sanofi pasteur msd ltd - a/california/7/2009 (h1n1)pdm09 - derived strain used nymc x-179a a/victoria/361/2011 (h3n2) - derived strain used ivr-165 b/massachusetts/2/2012 - suspension for injection - 7.5 mcg ea %v/v